Terug
Dagbereik
€ 283,93
€ 290,38
52-Weeksbereik
€ 273,71
€ 458,75
Volume
1.202.933
50D / 200D Gem.
€ 331,17
/
€ 331,99
Vorige Slotkoers
€ 289,24
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 11,3 | 0,3 |
| P/B | 1,5 | 2,9 |
| ROE % | 13,3 | 3,7 |
| Net Margin % | 2,8 | 3,8 |
| Rev Growth 5Y % | 9,5 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 382,64
+31.8%
Low: € 332,00
High: € 425,00
Forward K/W
11,2
Forward WPA
€ 25,86
WPA Groei (sch.)
+0,0%
Omzet Sch.
190 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 46,13
€ 43,90 – € 51,21
|
230 B | 2 |
| FY2029 |
€ 41,55
€ 39,55 – € 46,13
|
210 B | 2 |
| FY2028 |
€ 34,43
€ 31,50 – € 37,98
|
210 B | 4 |
Belangrijkste Punten
Revenue grew 9,47% annually over 5 years — modest growth
ROE of 13,29% — decent returns on equity
Generating 3,17B in free cash flow
P/E of 11,32 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,15%
Capital efficient — spends only 0,56% of revenue on capex
Groei
Revenue Growth (5Y)
9,47%
Revenue (1Y)12,62%
Earnings (1Y)-5,32%
FCF Growth (3Y)-31,50%
Kwaliteit
Return on Equity
13,29%
ROIC7,89%
Net Margin2,84%
Op. Margin4,07%
Veiligheid
Debt / Equity
0,76
Current Ratio1,24
Interest Coverage5,79
Waardering
P/E Ratio
11,32
P/B Ratio1,46
EV/EBITDA10,83
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,62% | Revenue Growth (3Y) | 7,80% |
| Earnings Growth (1Y) | -5,32% | Earnings Growth (3Y) | -2,75% |
| Revenue Growth (5Y) | 9,47% | Earnings Growth (5Y) | -1,86% |
| Profitability | |||
| Revenue (TTM) | 199,13B | Net Income (TTM) | 5,66B |
| ROE | 13,29% | ROA | 4,66% |
| Gross Margin | 25,56% | Operating Margin | 4,07% |
| Net Margin | 2,84% | Free Cash Flow (TTM) | 3,17B |
| ROIC | 7,89% | FCF Growth (3Y) | -31,50% |
| Safety | |||
| Debt / Equity | 0,76 | Current Ratio | 1,24 |
| Interest Coverage | 5,79 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 11,32 | P/B Ratio | 1,46 |
| P/S Ratio | 0,32 | PEG Ratio | -5,63 |
| EV/EBITDA | 10,83 | Dividend Yield | 0,02% |
| Market Cap | 64,08B | Enterprise Value | 87,82B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 199,13B | 176,81B | 171,34B | 156,60B | 138,64B |
| Net Income | 5,66B | 5,98B | 5,99B | 5,89B | 6,10B |
| EPS (Diluted) | 25,12 | 25,68 | 25,22 | 24,28 | 24,73 |
| Gross Profit | 50,90B | 49,24B | 47,01B | 39,95B | 35,99B |
| Operating Income | 8,11B | 8,89B | 8,75B | 8,45B | 8,95B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 121,49B | 116,89B | 108,93B | 102,76B | 97,46B |
| Total Liabilities | 77,47B | 75,46B | 69,52B | 66,43B | 61,33B |
| Shareholders' Equity | 43,88B | 41,32B | 39,31B | 36,24B | 36,06B |
| Total Debt | 33,24B | 32,70B | 26,65B | 25,80B | 24,89B |
| Cash & Equivalents | 9,49B | 8,29B | 6,53B | 7,39B | 4,88B |
| Current Assets | 24,73B | 21,34B | 18,99B | 19,13B | 14,57B |
| Current Liabilities | 19,96B | 19,42B | 19,55B | 18,65B | 15,53B |